XBiotech(XBIT) - 2021 Q4 - Annual Report

Commission file number 001-37437 ________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 XBIOTECH INC. FORM 10-K (Exact name of Registrant as specified in its charter) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 British Columbia, Canada N/A ☐ Transaction Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (State or other jurisdiction of inc ...